A Z Monica
- Address
- lock Available on a paid plan
Cardiovascular Disease Prevention Research
The cardiology department at A Z Monica in Antwerp is actively involved in research focused on preventing serious cardiovascular complications. The research primarily addresses atrial fibrillation, a condition characterized by irregular and often rapid heartbeat that significantly increases the risk of stroke and other cardiovascular events.
- Prevention of stroke and systemic embolism in patients with atrial fibrillation
- Evaluation of novel anticoagulation strategies
- Assessment of bleeding risk profiles in cardiovascular interventions
- Comparative effectiveness of therapeutic approaches
Clinical investigations aim to identify safer and more effective treatment options for patients at elevated stroke risk, balancing the prevention of thromboembolic events with the management of bleeding complications.
Oncology and Neuroendocrine Tumor Research
Research at this Belgian facility extends into the field of oncology, with particular emphasis on neuroendocrine tumours. These rare cancers arise from specialized cells throughout the body and present unique therapeutic challenges requiring specialized treatment approaches.
- Treatment strategies for neuroendocrine tumours following disease progression
- Role of somatostatin analogues in disease management
- Evaluation of second-line therapies including peptide receptor radionuclide therapy
- Quality of life assessment during cancer treatment
The investigations focus on optimizing therapeutic sequences and determining whether continuing certain treatments after initial progression provides clinical benefit, with careful attention to patient-reported outcomes and disease control.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in A Z Monica
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Continuing Somatostatin Analogues Upon progression in Neuroendocrine tumour pAtients (SAUNA trial) | Universitair Ziekenhuis Antwerpen | Phase III | Recruiting | Jun 2023 | — |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2017-07-31 | 2017-07-31 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.